Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
Recruiting · NCT05532696 · Registry updated 2024-06-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-06-24 | NCT05532696 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anbogen Therapeutics, Inc. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Memorial Hospital, Linkou | Taoyuan | Taiwan | 4 |
| National Cheng Kung University Hospital | Tainan | Taiwan | 52 |
| National Taiwan University Hospital | Taipei | Taiwan | 159 |
| Taichung Veterans General Hospital | Taichung | Taiwan | 111 |
| Taipei Medical Univresity Hospital | Taipei | Taiwan | 1 |